These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2645550)

  • 1. Adjunctive glaucoma therapy. A comparison of apraclonidine to dipivefrin when added to timolol maleate.
    Morrison JC; Robin AL
    Ophthalmology; 1989 Jan; 96(1):3-7. PubMed ID: 2645550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative ocular hypotensive effect of apraclonidine with timolol maleate in exfoliation versus primary open-angle glaucoma patients.
    Konstas AG; Maltezos A; Mantziris DA; Sine CS; Stewart WC
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():314-8. PubMed ID: 10624424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of apraclonidine as an adjunct to timolol therapy. Apraclonidine Adjunctive Therapy Study Group.
    Stewart WC; Ritch R; Shin DH; Lehmann RP; Shrader CE; van Buskirk EM
    Arch Ophthalmol; 1995 Mar; 113(3):287-92. PubMed ID: 7887841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.
    Stewart WC; Laibovitz R; Horwitz B; Stewart RH; Ritch R; Kottler M
    Arch Ophthalmol; 1996 Aug; 114(8):938-42. PubMed ID: 8694728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study.
    Nagasubramanian S; Hitchings RA; Demailly P; Chuniaud M; Pannarale MR; Pecori-Giraldi J; Stodtmeister R; Parsons DG
    Ophthalmology; 1993 Sep; 100(9):1318-23. PubMed ID: 8371918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and effectiveness of concomitant administration of dipivefrin and timolol maleate.
    Keates EU; Stone RA
    Am J Ophthalmol; 1981 Feb; 91(2):243-8. PubMed ID: 7468740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic response interactions between timolol maleate and dipivefrin hydrochloride.
    West RH; Gillies WE; Brooks AM
    Aust N Z J Ophthalmol; 1987 May; 15(2):131-4. PubMed ID: 3620185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apraclonidine hydrochloride: an evaluation of plasma concentrations, and a comparison of its intraocular pressure lowering and cardiovascular effects to timolol maleate.
    Robin AL; Coleman AL
    Trans Am Ophthalmol Soc; 1990; 88():149-59; discussion 159-62. PubMed ID: 1982747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of levobunolol and dipivefrin for the treatment of glaucoma.
    Allen RC; Robin AL; Long D; Novack GD; Lue JC; Kaplan G
    Arch Ophthalmol; 1988 Jul; 106(7):904-7. PubMed ID: 3291837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of topical flurbiprofen on the intraocular pressure lowering effects of apraclonidine and timolol.
    Sulewski ME; Robin AL; Cummings HL; Arkin LM
    Arch Ophthalmol; 1991 Jun; 109(6):807-9. PubMed ID: 1675049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect and side effects of apraclonidine].
    Stewart WC
    Klin Monbl Augenheilkd; 1996 Jul; 209(1):A7-13. PubMed ID: 8965469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of timolol and epinephrine on intraocular pressure.
    Moss AP; Ritch R; Hargett NA; Kohn AN; Smith H; Podos SM
    Am J Ophthalmol; 1978 Oct; 86(4):489-95. PubMed ID: 360846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin DH; Smythe B; Mundorf T; Lehmann RP
    Am J Ophthalmol; 1995 Oct; 120(4):423-32. PubMed ID: 7573299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timolol and epinephrine: long-term evaluation of concurrent administration.
    Korey MS; Hodapp E; Kass MA; Goldberg I; Gordon M; Becker B
    Arch Ophthalmol; 1982 May; 100(5):742-5. PubMed ID: 7044351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical apraclonidine hydrochloride in eyes with poorly controlled glaucoma. The Apraclonidine Maximum Tolerated Medical Therapy Study Group.
    Robin AL; Ritch R; Shin D; Smythe B; Mundorf T; Lehmann RP
    Trans Am Ophthalmol Soc; 1995; 93():421-38; discussion 439-41. PubMed ID: 8719690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of epinephrine and dipivefrin in patients using timolol: a single-dose study.
    Blondeau P; Côté M
    Can J Ophthalmol; 1984 Feb; 19(1):29-32. PubMed ID: 6713266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of apraclonidine hydrochloride in laser therapy for glaucoma.
    Robin AL
    Trans Am Ophthalmol Soc; 1989; 87():729-61. PubMed ID: 2562547
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive effect of 1% apraclonidine hydrochloride to nonselective beta-blockers.
    Yaldo MK; Shin DH; Parrow KA; Lee SH; Lee SY
    Ophthalmology; 1991 Jul; 98(7):1075-8. PubMed ID: 1679916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.